Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

  • Toshihiko Kaneda1,
  • Hiroshige Yoshioka1Email author,
  • Motohiro Tamiya2,
  • Akihiro Tamiya3,
  • Akito Hata4,
  • Asukaka Okada5,
  • Takashi Niwa1,
  • Takayuki Shiroyama2,
  • Masaki Kanazu3,
  • Tadashi Ishida1 and
  • Nobuyuki Katakami4
BMC Cancer201818:6

https://doi.org/10.1186/s12885-017-3952-7

Received: 25 January 2017

Accepted: 21 December 2017

Published: 2 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
25 Jan 2017 Submitted Original manuscript
6 Mar 2017 Reviewed Reviewer Report - Anthony C Faber
18 Mar 2017 Reviewed Reviewer Report - Muhammad Shahdaat Bin Sayeed
15 May 2017 Author responded Author comments - Toshihiko Kaneda
Resubmission - Version 2
15 May 2017 Submitted Manuscript version 2
23 Aug 2017 Reviewed Reviewer Report - Ikuo Sekine
4 Oct 2017 Reviewed Reviewer Report - Anthony C Faber
3 Dec 2017 Author responded Author comments - Toshihiko Kaneda
Resubmission - Version 3
3 Dec 2017 Submitted Manuscript version 3
13 Dec 2017 Reviewed Reviewer Report - Ikuo Sekine
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Dec 2017 Editorially accepted
2 Jan 2018 Article published 10.1186/s12885-017-3952-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan
(2)
Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino, Japan
(3)
Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan
(4)
Division of Integrated Oncology, Institute of Biomedical Research and Innovation, Kobe, Japan
(5)
Department of Respiratory Medicine, Saiseikai Suita Hospital, Suita, Japan

Advertisement